Bellus Health Inc. Stock Predictions

NASDAQ Stock Exchange > Healthcare > Biotechnology

Open Broker Account

$14.74

+0 (+0%)

At Close: Sep 27, 2023

Currently predicting for Thu, 2 May 2024

BLU Predictions History

1 year ago
JS predicted that BLU for 2022-06-29 is going $9.23 (-7.88%)

3 years ago
JS predicted that BLU for 2021-02-22 is going $4.70 (12.17%)

3 years ago
JS predicted that BLU for 2020-12-28 is going $3.08 (0.00%)

3 years ago
RK predicted that BLU for 2020-12-28 is going $4.50 (46.10%)

Rank:

3 years ago
JS predicted that BLU for 2020-11-23 is going $3.18 (-0.93%)

3 years ago
JS predicted that BLU for 2020-11-20 is going $3.11 (-3.12%)

About Bellus Health Inc.

BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. The company was incorporated in 1993 and is based in Laval, Canada.... BLU Profile

Golden Star

Ticker	Date	Change	Price
HRB	Apr 29	1.00%	$47.23
LYG	Apr 29	0.391%	$2.56
ORA	Apr 29	1.95%	$64.48
ETSY	Apr 26	3.43%	$67.43
DHT	Apr 24	0.98%	$11.28
LPLA	Apr 19	1.10%	$262.59
MLI	Apr 19	7.29%	$52.28
PFLT	Apr 18	1.33%	$11.25
DOOR	Apr 18	0.94%	$131.39
OCSL	Apr 17	0.360%	$19.43

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In

Bellus Health Inc. Stock Predictions

BLU Predictions History

About Bellus Health Inc.

Golden Star

Top Fintech Company